CN102614413A - 一种治疗小儿鼻窦炎的中药组合物及其制备方法 - Google Patents
一种治疗小儿鼻窦炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102614413A CN102614413A CN2012101281925A CN201210128192A CN102614413A CN 102614413 A CN102614413 A CN 102614413A CN 2012101281925 A CN2012101281925 A CN 2012101281925A CN 201210128192 A CN201210128192 A CN 201210128192A CN 102614413 A CN102614413 A CN 102614413A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- flos
- chinese medicine
- sinusitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000009890 sinusitis Diseases 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 117
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000218378 Magnolia Species 0.000 claims abstract description 3
- 241000206469 Pulsatilla Species 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 229940079593 drug Drugs 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 31
- 238000010438 heat treatment Methods 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 22
- 238000000605 extraction Methods 0.000 claims description 21
- 238000001914 filtration Methods 0.000 claims description 18
- 240000005819 Magnolia denudata Species 0.000 claims description 17
- 235000016094 Magnolia denudata Nutrition 0.000 claims description 17
- 241000566693 Asteriscus Species 0.000 claims description 15
- 238000010992 reflux Methods 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 241001610348 Monetaria annulus Species 0.000 claims description 13
- 241001610350 Monetaria moneta Species 0.000 claims description 13
- 235000011201 Ginkgo Nutrition 0.000 claims description 12
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 12
- 238000004821 distillation Methods 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 11
- 238000002347 injection Methods 0.000 claims description 11
- 239000007924 injection Substances 0.000 claims description 11
- 241000218628 Ginkgo Species 0.000 claims description 10
- 239000009806 pulsatillae Substances 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000011347 resin Substances 0.000 claims description 9
- 229920005989 resin Polymers 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- 235000008504 concentrate Nutrition 0.000 claims description 6
- 239000013078 crystal Substances 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 235000011837 pasties Nutrition 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- 239000000829 suppository Substances 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 230000000274 adsorptive effect Effects 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 230000008719 thickening Effects 0.000 claims description 3
- 241000592346 Ginkgophyta Species 0.000 claims description 2
- 241001596954 Larimichthys Species 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 235000003956 Luffa Nutrition 0.000 claims description 2
- 244000050983 Luffa operculata Species 0.000 claims description 2
- 235000014435 Mentha Nutrition 0.000 claims description 2
- 241001072983 Mentha Species 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 230000002262 irrigation Effects 0.000 claims description 2
- 238000003973 irrigation Methods 0.000 claims description 2
- 235000020068 maotai Nutrition 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 42
- 210000004369 blood Anatomy 0.000 abstract description 26
- 239000008280 blood Substances 0.000 abstract description 26
- 201000010099 disease Diseases 0.000 abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 20
- 230000001717 pathogenic effect Effects 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 3
- 239000004575 stone Substances 0.000 abstract description 2
- 240000002245 Acer pensylvanicum Species 0.000 abstract 1
- 235000006760 Acer pensylvanicum Nutrition 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000010576 Artemisia cina Nutrition 0.000 abstract 1
- 241000481605 Bolbostemma paniculatum Species 0.000 abstract 1
- 240000004183 Bongardia chrysogonum Species 0.000 abstract 1
- 244000056139 Brassica cretica Species 0.000 abstract 1
- 235000003351 Brassica cretica Nutrition 0.000 abstract 1
- 235000003343 Brassica rupestris Nutrition 0.000 abstract 1
- 244000281762 Chenopodium ambrosioides Species 0.000 abstract 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 abstract 1
- 240000001980 Cucurbita pepo Species 0.000 abstract 1
- 235000009852 Cucurbita pepo Nutrition 0.000 abstract 1
- 244000214240 Galinsoga parviflora Species 0.000 abstract 1
- 235000018914 Galinsoga parviflora Nutrition 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241001596950 Larimichthys crocea Species 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 241000218394 Magnolia liliiflora Species 0.000 abstract 1
- 241000304370 Orostachys Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000070669 Solanum ferox Species 0.000 abstract 1
- 235000018253 Solanum ferox Nutrition 0.000 abstract 1
- 235000000914 Solidago virgaurea Nutrition 0.000 abstract 1
- 240000007284 Stenochlaena palustris Species 0.000 abstract 1
- 241001072888 Teucrium Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 abstract 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N lead(II) oxide Inorganic materials [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 235000010460 mustard Nutrition 0.000 abstract 1
- 244000112814 pipewort Species 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 26
- 235000019634 flavors Nutrition 0.000 description 26
- 230000006870 function Effects 0.000 description 21
- 210000004072 lung Anatomy 0.000 description 21
- 241000700199 Cavia porcellus Species 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 19
- 210000001331 nose Anatomy 0.000 description 19
- 231100000614 poison Toxicity 0.000 description 19
- 206010019233 Headaches Diseases 0.000 description 16
- 231100000869 headache Toxicity 0.000 description 16
- 210000000214 mouth Anatomy 0.000 description 16
- 208000033809 Suppuration Diseases 0.000 description 15
- 241000411851 herbal medicine Species 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 14
- 206010028748 Nasal obstruction Diseases 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 14
- 230000008961 swelling Effects 0.000 description 14
- 239000003440 toxic substance Substances 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 206010022000 influenza Diseases 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 210000004877 mucosa Anatomy 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 210000002850 nasal mucosa Anatomy 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 8
- 241000475481 Nebula Species 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 239000002398 materia medica Substances 0.000 description 8
- 210000003695 paranasal sinus Anatomy 0.000 description 8
- 206010039083 rhinitis Diseases 0.000 description 8
- 231100000331 toxic Toxicity 0.000 description 8
- 230000002588 toxic effect Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 206010018691 Granuloma Diseases 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000000416 exudates and transudate Anatomy 0.000 description 7
- 210000003928 nasal cavity Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 206010020880 Hypertrophy Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 235000015170 shellfish Nutrition 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010020565 Hyperaemia Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000000959 ear middle Anatomy 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 229940023488 pill Drugs 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 206010044008 tonsillitis Diseases 0.000 description 5
- 240000006409 Acacia auriculiformis Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 241000201295 Euphrasia Species 0.000 description 4
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000035617 depilation Effects 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 210000005069 ears Anatomy 0.000 description 4
- 210000001508 eye Anatomy 0.000 description 4
- 210000001061 forehead Anatomy 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 229940100691 oral capsule Drugs 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000035943 smell Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 208000004371 toothache Diseases 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 206010002653 Anosmia Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 206010039085 Rhinitis allergic Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000009911 Urinary Calculi Diseases 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 201000010105 allergic rhinitis Diseases 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000003118 histopathologic effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- MFIHSKBTNZNJIK-RZTYQLBFSA-N (3s,3ar,6s,6ar)-3-(3,4-dimethoxyphenyl)-6-(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(OC)=C(OC)C=3)[C@@H]2CO1 MFIHSKBTNZNJIK-RZTYQLBFSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 241000242759 Actiniaria Species 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 2
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010050515 Hyposmia Diseases 0.000 description 2
- 206010024453 Ligament sprain Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 206010028720 Nasal abscess Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- 206010037569 Purulent discharge Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000026137 Soft tissue injury Diseases 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 241000053227 Themus Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 235000020960 dehydroascorbic acid Nutrition 0.000 description 2
- 239000011615 dehydroascorbic acid Substances 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 210000000883 ear external Anatomy 0.000 description 2
- 210000003094 ear ossicle Anatomy 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 229960000785 fluocinonide Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 235000019559 hyposmia Nutrition 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 201000003265 lymphadenitis Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 210000004086 maxillary sinus Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000011050 natural pearl Substances 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000037922 refractory disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000001944 turbinate Anatomy 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- YLRXAIKMLINXQY-ZDUSSCGKSA-O (S)-magnoflorine Chemical compound C1=C(OC)C(O)=C2C3=C(O)C(OC)=CC=C3C[C@@H]3[N+](C)(C)CCC1=C23 YLRXAIKMLINXQY-ZDUSSCGKSA-O 0.000 description 1
- 206010001076 Acute sinusitis Diseases 0.000 description 1
- KMOUJOKENFFTPU-UHFFFAOYSA-N Apigenin-7-glucosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-UHFFFAOYSA-N 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 208000013017 Child Nutrition disease Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010009137 Chronic sinusitis Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- ACBOFPQSBWBAQR-UHFFFAOYSA-N Cosmosiin Natural products OCC1OC(Oc2cc(O)c3C(=O)C=C(Oc3c2)c4cccc(O)c4)C(O)C(O)C1O ACBOFPQSBWBAQR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 244000297531 Lespedeza cuneata Species 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KYEAXNAYHSCLMT-CVVGWEDFSA-N Magnoflorine Natural products C[C@H]1OC=C2[C@@H]3[C@@H]1CN4CCc5c([nH]c6ccccc56)[C@@H]4[C@@H]3OC2=O KYEAXNAYHSCLMT-CVVGWEDFSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 231100000757 Microbial toxin Toxicity 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241001113283 Respirovirus Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 240000005578 Rivina humilis Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010070488 Upper-airway cough syndrome Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000019558 anosmia Nutrition 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KMOUJOKENFFTPU-QNDFHXLGSA-N apigenin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-QNDFHXLGSA-N 0.000 description 1
- KMOUJOKENFFTPU-JOZSIVFUSA-N apigenin-7-O-beta-D-glucopyranoside Natural products OC[C@@H]1O[C@@H](Oc2cc(O)c3c(c2)oc(cc3=O)-c2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O KMOUJOKENFFTPU-JOZSIVFUSA-N 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 208000037817 intestinal injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000013010 irrigating solution Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- MFIHSKBTNZNJIK-UHFFFAOYSA-N medioresinol dimethyl ether Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C(OC)C(OC)=C(OC)C=3)C2CO1 MFIHSKBTNZNJIK-UHFFFAOYSA-N 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | n | 肉芽肿重量(g) |
模型组 | 10 | 0.12532±0.015673 |
醋酸氟轻松组 | 10 | 0.09873±0.009634* |
本发明高剂量组 | 10 | 0.06548±0.008763* |
本发明低剂量组 | 10 | 0.08643±0.000621 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210128192 CN102614413B (zh) | 2012-04-28 | 2012-04-28 | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210128192 CN102614413B (zh) | 2012-04-28 | 2012-04-28 | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102614413A true CN102614413A (zh) | 2012-08-01 |
CN102614413B CN102614413B (zh) | 2013-08-07 |
Family
ID=46554861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210128192 Active CN102614413B (zh) | 2012-04-28 | 2012-04-28 | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102614413B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103877429A (zh) * | 2014-04-19 | 2014-06-25 | 郭冬梅 | 一种治疗鼻窦炎的中药制剂及制备方法 |
CN104667191A (zh) * | 2015-03-20 | 2015-06-03 | 杜卫卫 | 一种治疗过敏性鼻炎的药物组合物 |
CN104971264A (zh) * | 2015-08-10 | 2015-10-14 | 王艳娣 | 一种治疗小儿慢性鼻窦炎的中药组合物 |
CN105168669A (zh) * | 2015-10-28 | 2015-12-23 | 郭旺水 | 一种治疗中耳炎的中药组合物及其制备方法和用途 |
RU2718699C1 (ru) * | 2019-09-16 | 2020-04-14 | Татьяна Борисовна Корженевская | Способ лечения рецидивирующих бактериальных осложнений придаточных пазух носа у детей в стадии обострения на фоне головных болей |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1078636A (zh) * | 1992-05-12 | 1993-11-24 | 范占强 | 一种治疗鼻炎的药物组合物及其制备方法 |
CN1824142A (zh) * | 2005-12-28 | 2006-08-30 | 仲崇玉 | 一种治疗鼻窦炎的中药剂及其制备方法 |
CN101491621A (zh) * | 2009-03-12 | 2009-07-29 | 许建成 | 一种治疗鼻窦炎的中药组合物及其制备方法 |
CN102205026A (zh) * | 2011-05-27 | 2011-10-05 | 李佃场 | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 |
CN102228543A (zh) * | 2011-07-05 | 2011-11-02 | 河南科技大学 | 一种用于治疗鼻炎、鼻窦炎的中药组合物及其制备方法 |
-
2012
- 2012-04-28 CN CN 201210128192 patent/CN102614413B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1078636A (zh) * | 1992-05-12 | 1993-11-24 | 范占强 | 一种治疗鼻炎的药物组合物及其制备方法 |
CN1824142A (zh) * | 2005-12-28 | 2006-08-30 | 仲崇玉 | 一种治疗鼻窦炎的中药剂及其制备方法 |
CN101491621A (zh) * | 2009-03-12 | 2009-07-29 | 许建成 | 一种治疗鼻窦炎的中药组合物及其制备方法 |
CN102205026A (zh) * | 2011-05-27 | 2011-10-05 | 李佃场 | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 |
CN102228543A (zh) * | 2011-07-05 | 2011-11-02 | 河南科技大学 | 一种用于治疗鼻炎、鼻窦炎的中药组合物及其制备方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103877429A (zh) * | 2014-04-19 | 2014-06-25 | 郭冬梅 | 一种治疗鼻窦炎的中药制剂及制备方法 |
CN104667191A (zh) * | 2015-03-20 | 2015-06-03 | 杜卫卫 | 一种治疗过敏性鼻炎的药物组合物 |
CN104971264A (zh) * | 2015-08-10 | 2015-10-14 | 王艳娣 | 一种治疗小儿慢性鼻窦炎的中药组合物 |
CN105168669A (zh) * | 2015-10-28 | 2015-12-23 | 郭旺水 | 一种治疗中耳炎的中药组合物及其制备方法和用途 |
RU2718699C1 (ru) * | 2019-09-16 | 2020-04-14 | Татьяна Борисовна Корженевская | Способ лечения рецидивирующих бактериальных осложнений придаточных пазух носа у детей в стадии обострения на фоне головных болей |
Also Published As
Publication number | Publication date |
---|---|
CN102614413B (zh) | 2013-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102198236B (zh) | 一种治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN102139030B (zh) | 一种治疗牙龈炎的口腔中药制剂及其制备方法 | |
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN102526441B (zh) | 一种专治妇科炎症的中药冲洗液 | |
CN103638250B (zh) | 一种治疗面神经***中药制剂及其制备方法 | |
CN102614413B (zh) | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 | |
CN103432475A (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN104117005A (zh) | 一种治疗热射病的中药制剂及其制备方法 | |
CN103720841A (zh) | 一种治疗慢性化脓性中耳炎的中药制剂及其制备方法 | |
CN103495072B (zh) | 一种治疗支气管扩张病的中药组合物及其制备方法 | |
CN105412697A (zh) | 一种清热除湿、保肝利胆的佩兰口服液及其制备方法 | |
CN104189307A (zh) | 一种治疗耳聋耳鸣的中药及其制备方法 | |
CN103520643B (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
CN105521235A (zh) | 一种止痒药液 | |
CN106880758A (zh) | 一种用于外阴瘙痒和湿疹皮炎顽癣的中药制剂及制备方法 | |
CN104997949A (zh) | 一种治疗鼻炎的中药组合物及其制备方法 | |
CN104740403A (zh) | 一种治疗血虚阴亏型复发性口腔溃疡的药物及其制备方法 | |
CN104667191A (zh) | 一种治疗过敏性鼻炎的药物组合物 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
CN104840823A (zh) | 一种治疗中耳炎的中药制剂及制法 | |
CN104784558A (zh) | 一种治疗复发性口腔溃疡的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG HAOYOUXIAN AQUATIC FOOD CO., LTD. Free format text: FORMER OWNER: CAO GUANGXUE Effective date: 20140801 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 273500 JINING, SHANDONG PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140801 Address after: 226200 Qidong City, Jiangsu Province, Lu Lu, the Marine Economic Development Zone, four Patentee after: Nantong good and fresh aquatic food Co., Ltd. Address before: 273500 Shandong city of Jining province Zoucheng City Experimental Middle School (Yi Road No. 769) Patentee before: Cao Guangxue |